Navin Fluorine International Limited · NSE:NAVINFLUOR

Navin Fluorine International — Investor Presentation (November 2015)

31 slides from Navin Fluorine International's investor presentation, November 2015

  1. Slide 1: Navin Fluorine International Limited Investor Presentation

    Navin Fluorine International Limited Investor Presentation November 2015

  2. Slide 2: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe

  3. Slide 3: Navin Fluorine International Limited

    Navin Fluorine International Limited Building “India’s only plant with high pressure fluorination capabilities with Largest Integrated Specialty cGMP compliance” for CRAMS Business Fluorochemical Company in India Manufacturing plants Over 45 years of expertise strategically located in Handling Fluor

  4. Slide 4: Fluorine Chemistry – A Growing Landscape

    Fluorine Chemistry – A Growing Landscape Global demand for Fluoro-chemicals in 2018 to reach 4.0 Millon MT , with CAGR of 4% per annum Pharmaceuticals Agriculture Electronics Steel Solar / Energy Aluminum White Goods Automotive Glass 4

  5. Slide 5: Evolution of NFIL

    Evolution of NFIL 2015… …2013  Focus on CRAMS & Specialty Chemical Segment to drive growth  CRAMS expansion at Dewas  Commenced CRAMS business in 2011  JV with Piramal Enterprises at Dahej  Acquisition of 51% equity stake in Manchester  Acquired balance 49% stake in MOL Organics Ltd. (MOL) in

  6. Slide 6: Professional Management

    Professional Management Mr. H.A. Mafatlal – Chairman Professional Team …. Mr. Shekhar Khanolkar : Managing Director Chemical Engineer with Masters in Management studies and an alumni of Harvard Business School Spent more than 21 years in the Chemical industry with both Indian & Multinational Chemica

  7. Slide 7: Business Units (BU) - Standalone

    Business Units (BU) - Standalone FY11 – Revenue % FY15 – Revenue % Commenced CRAMS business in 2011 CRAMS – 0% CRAMS – 6% Commenced Specialty Chemicals in Specialty Specialty 2000 Chemicals – 27% Chemicals –39% Inorganic Fluorides & Inorganic Inorganic Refrigerants are Fluorides – 18% Fluorides –19%

  8. Slide 8: Refrigerants, Inorganic Fluorides: Sustainable and Stable BUs

    Refrigerants Inorganic Fluorides Sustainable and Stable BUs 8

  9. Slide 9: Refrigerants: Growing Demand for Non-Emissive applications

    Refrigerants : Growing Demand for Non-Emissive applications Product User Distribution Export Offering Base Network Outreach  Pioneered  Used in Residential Air  Strong Distribution  Exports to South-East manufacturing of Conditioning Network of over 120 Asia, Middle East, Saudi refrigerant gases

  10. Slide 10: Inorganic Fluorides: Growth from Exports

    Inorganic Fluorides : Growth from Exports Product User Distribution Export Offering Base Network Outreach  Portfolio includes 8-10  Oil & Gas Industry  Developed Strong  Growing exports products network in India  Stainless Steel  From near Zero to ~10%  One of the largest  Presence in all ma

  11. Slide 11: BU Performance and Geographic Mix – FY15

    BU Performance Refrigerants Inorganic Fluorides CAGR +5% Revenue (Rs.Crs) CAGR +8% 195 194 113 105 176 98 99 161 154 77 FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13 FY14 FY15 Exports Geographic Mix – FY15 9% Exports 32% 68% Domestic 91% Domestic 11

  12. Slide 12: Specialty Chemicals and CRAMS

    Specialty Chemicals CRAMS Driving up the “Fluorine Value chain” 12

  13. Slide 13: Specialty Chemicals: Growing product basket

    Specialty Chemicals : Growing product basket Product  Strong Portfolio of value added Specialty Fluoro intermediates Offering  Introduction of novel molecules to expand portfolio  Used by Pharma, Agchem, Petrochem industries User  Focus on deeper penetrating into existing users and Base particip

  14. Slide 14: CRAMS: Scalable Growth through Innovation

    CRAMS : Scalable Growth through INNOVATION Strong R&D  Leveraging our proven skills in Developing Contract Fluorination Chemistry Manufacturing Base  State of the art R&D led by qualified and experienced  Setting up manufacturing facility chemistry teams of PhDs & Post for multi-ton batch size, a

  15. Slide 15: Manchester Organics - In Perfect Synergy with CRAMS

    Manchester Organics - In Perfect Synergy with CRAMS  Offer over 60 years of combined  Established in 1996, Manchester Organic chemistry experience to customers Ltd (MOL) has a strong legacy in fluorination and high pressure chemistry  Milligram to multi-kilo research/production  Specialist in fl

  16. Slide 16: MOL Performance

    MOL Performance Revenue (Rs.Crs) PBT (Rs.Crs) +16% +76% 49 8 42 5 FY14 FY15 FY14 FY15 PAT (Rs.Crs) PAT Margin % + 434 bps +62% 15.39% 7 11.05% 5 FY14 FY15 FY14 FY15 16

  17. Slide 17: BU Performance and Geographic Mix – FY15

    BU Performance Specialty Chemicals CRAMS* Revenue (Rs.Crs) CAGR +16% CAGR +49% 215 31 178 26 159 156 118 14 FY11 FY12 FY13 FY14 FY15 FY13 FY14 FY15 Domestic Geographic Mix – FY15 4% Exports 32% 68% Domestic 96% Exports 17 * CRAMS business generating revenue from FY13

  18. Slide 18: JV with Piramal Enterprises

    JV with Piramal Enterprises  Entered into JV with Piramal Enterprises Ltd  51% - Piramal Enterprises Ltd  49% - Navin Fluorine International Ltd  To develop, manufacture & sell specialty Fluorochemicals for the healthcare segment  Initial investment - ~Rs. 120 Crs. Current estimates of investme

  19. Slide 19: Clients across the Globe

    ry Clients across the Globe tieaeten cad? CLARIANT™ ay Bayer syngenta Cy) Bayer CropScience ~ SUN oo. : a anaadl “torneso t) Novartis LUPIN PHARMACEUTICALS, INC. AURC 2BINDC a itted to Healthier oF - Y Dr.Reppy's IPE. RESEARCH . HOPE Ea BLUE STAR 19 ARVIND Marattat Grour

  20. Slide 20: Key Strengths

    Key Strengths Fluorination Capabilities In-house R&D  Pioneered Manufacturing of  State-of-the-art R&D centre – Navin Refrigerant Gases in India Research Innovation Centre at Surat  Over 45 years of experience in  DSIR approved R&D Centre handling Fluorine  Supports in product addition &  Exte

  21. Slide 21: Growth driven by Every Business Unit

    Growth driven by Every Business Unit CRAMS  Business progression from Contract research to contract manufacturing  Manufacturing facility to be operational from FY16 Specialty Chemicals  Introduction of new high value added molecules in portfolio  Entry into newer geographies Inorganic Fluorides

  22. Slide 22: Quarterly Financial Performance

    Quarterly Financial Performance 22

  23. Slide 23: BU Performance and Geographic Mix – H1 FY16

    Business Units Performance Refrigerants Inorganic Fluorides Revenue (Rs.Crs) 195 194 113 105 176 98 99 154 113 46 FY12 FY13 FY14 FY15 H1 FY16 FY12 FY13 FY14 FY15 H1 FY16 Exports Geographic Mix – H1 FY16 11% Exports 42% Domestic 58% Domestic 89% 23

  24. Slide 24: BU Performance and Geographic Mix – H1 FY16

    Business Units Performance Specialty Chemicals CRAMS* Revenue (Rs.Crs) 215 31 178 26 159 156 20 121 14 FY12 FY13 FY14 FY15 H1 FY16 FY13 FY14 FY15 H1 FY16 Domestic 0% Geographic Mix – H1 FY16 Domestic Exports Exports 47% 100% 53% 24 * CRAMS business generating revenue since FY13

  25. Slide 25: Standalone Profitability Statement - Quarterly

    Standalone Profitability Statement - Quarterly Rs. Crs. Q2 FY16 Q2 FY15 Change % H1 FY16 H1 FY15 Change % FY15 Revenue 151 124 22% 301 254 19% 546 Raw Material 63 59 134 124 272 Employee Expenses 15 14 31 31 61 Other Expenses 41 38 78 74 150 EBITDA 32 14 129% 57 26 119% 63 EBITDA Margin 21.0% 11.2%

  26. Slide 26: Standalone Balance Sheet

    Standalone Balance Sheet Rs. Crs. Sep-15 Mar-15 Rs. Crs. Sep-15 Mar-15 Shareholder’s Fund Non-current assets Share capital 10 10 Fixed assets 286 270 Reserves & Surplus 591 561 Non Current Investments 201 179 Non-current liabilities Long-term loans and advances 48 68 Long term borrowings - 12 Curren

  27. Slide 27: Consistent Dividend Performance

    Consistent Dividend Performance Dividend as % of Face Value Robust Dividend Payout 160% 160%  Continuous Dividend 150% 150% 150% 140% since last 10 years Declared Highest ever Interim Dividend @ 100%  Special Dividend of Rs. 60 per share in FY 12  Payout Ratio of more than 30% in last 4 years  T

  28. Slide 28: Historical Financial Highlights

    Historical Financial Highlights 28

  29. Slide 29: Consolidated Profitability Statement

    Consolidated Profitability Statement Rs. Crs. FY15 FY14 Change % Revenue 592 486 22% Raw Material 289 228 Employee Expenses 74 59 Other Expenses 156 133 EBITDA 72 66 9.4% EBITDA Margin 12.2% 13.6% Interest Expenses 3 6 Depreciation 20 22 Operating PBT 49 39 26% Operating PBT Margin 8.24% 7.94% Other

  30. Slide 30: Consolidated Balance Sheet

    Consolidated Balance Sheet Rs. Crs. Mar’15 Mar’14 Shareholder’s Fund Share capital 10 10 Reserves & Surplus 578 546 Minority Interest 13 9 Non-current liabilities Long term borrowings 27 - Deferred Tax Liabilities (net) 32 33 Other non-current liabilities 28 28 Current liabilities Short term borrowi

  31. Slide 31: Contact

    Contact For further information, please contact: Company : Investor Relations Advisors : Navin Fluorine International Ltd. Strategic Growth Advisors Pvt. Ltd. CIN : L24110MH1998PLC115499 CIN : U74140MH2010PTC204285 Mr. Sitendu Nagchaudhri Ms. Sanjita Ghosh / Mr. Shogun Jain Chief Financial Officer 0

Navin Fluorine International — Investor Presentation (November 2015) on 6ix